Literature DB >> 31996430

An Influenza Virus Hemagglutinin Computationally Optimized Broadly Reactive Antigen Elicits Antibodies Endowed with Group 1 Heterosubtypic Breadth against Swine Influenza Viruses.

Amanda L Skarlupka1, Z Beau Reneer1, Rodrigo B Abreu1, Ted M Ross1,2, Giuseppe A Sautto3.   

Abstract

Entities:  

Keywords:  COBRA; influenza vaccine; influenza virus; monoclonal antibodies; swine influenza virus

Year:  2020        PMID： 31996430      PMCID： PMC7108850          DOI： 10.1128/JVI.02061-19

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


× No keyword cloud information.
  12 in total

1.  Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.

Authors:  Donald M Carter; Christopher A Darby; Bradford C Lefoley; Corey J Crevar; Timothy Alefantis; Raymond Oomen; Stephen F Anderson; Tod Strugnell; Guadalupe Cortés-Garcia; Thorsten U Vogel; Mark Parrington; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  Elicitation of Broadly Protective Antibodies following Infection with Influenza Viruses Expressing H1N1 Computationally Optimized Broadly Reactive Hemagglutinin Antigens.

Authors:  Giuseppe A Sautto; Greg A Kirchenbaum; Jeffrey W Ecker; Anne-Gaelle Bebin-Blackwell; Spencer R Pierce; Ted M Ross
Journal:  Immunohorizons       Date:  2018-08-27

3.  Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.

Authors:  James D Allen; Hyesun Jang; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

4.  Hemagglutinin consensus-based prophylactic approaches to overcome influenza virus diversity.

Authors:  Giuseppe Andrea Sautto; Ted M Ross
Journal:  Vet Ital       Date:  2019-09-30       Impact factor: 1.101

5.  Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.

Authors:  Donald M Carter; Christopher A Darby; Scott K Johnson; Michael A Carlock; Greg A Kirchenbaum; James D Allen; Thorsten U Vogel; Simon Delagrave; Joshua DiNapoli; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2017-11-30       Impact factor: 5.103

6.  Mapping the antigenic and genetic evolution of influenza virus.

Authors:  Derek J Smith; Alan S Lapedes; Jan C de Jong; Theo M Bestebroer; Guus F Rimmelzwaan; Albert D M E Osterhaus; Ron A M Fouchier
Journal:  Science       Date:  2004-06-24       Impact factor: 47.728

7.  Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.

Authors:  James D Allen; Satyajit Ray; Ted M Ross
Journal:  PLoS One       Date:  2018-09-28       Impact factor: 3.240

8.  Next Generation Vaccines for Infectious Diseases.

Authors:  Giuseppe A Sautto; Greg A Kirchenbaum; Roberta A Diotti; Elena Criscuolo; Francesca Ferrara
Journal:  J Immunol Res       Date:  2019-04-30       Impact factor: 4.818

9.  Computationally optimized broadly reactive vaccine based upon swine H1N1 influenza hemagglutinin sequences protects against both swine and human isolated viruses.

Authors:  Amanda L Skarlupka; Simon O Owino; Lui P Suzuki-Williams; Corey J Crevar; Donald M Carter; Ted M Ross
Journal:  Hum Vaccin Immunother       Date:  2019       Impact factor: 3.452

Review 10.  Towards a universal influenza vaccine: different approaches for one goal.

Authors:  Giuseppe A Sautto; Greg A Kirchenbaum; Ted M Ross
Journal:  Virol J       Date:  2018-01-19       Impact factor: 4.099
View more
  5 in total

1.  An H1N1 Computationally Optimized Broadly Reactive Antigen Elicits a Neutralizing Antibody Response against an Emerging Human-Infecting Eurasian Avian-Like Swine Influenza Virus.

Authors:  Giuseppe A Sautto; Jeffrey W Ecker; Ted M Ross
Journal:  J Virol       Date:  2021-06-10       Impact factor: 5.103

2.  A Competitive Hemagglutination Inhibition Assay for Dissecting Functional Antibody Activity against Influenza Virus.

Authors:  Greg A Kirchenbaum; Giuseppe A Sautto; Robert A Richardson; Jeffrey W Ecker; Ted M Ross
Journal:  J Virol       Date:  2021-09-15       Impact factor: 5.103

Review 3.  Protein engineering strategies for rational immunogen design.

Authors:  Timothy M Caradonna; Aaron G Schmidt
Journal:  NPJ Vaccines       Date:  2021-12-17       Impact factor: 7.344

4.  Dual oxidase 1 promotes antiviral innate immunity.

Authors:  Demba Sarr; Aaron D Gingerich; Nuha Milad Asthiwi; Faris Almutairi; Giuseppe A Sautto; Jeffrey Ecker; Tamás Nagy; Matthew B Kilgore; Joshua D Chandler; Ted M Ross; Ralph A Tripp; Balázs Rada
Journal:  Proc Natl Acad Sci U S A       Date:  2021-06-29       Impact factor: 11.205

5.  Convergent antibody evolution and clonotype expansion following influenza virus vaccination.

Authors:  David Forgacs; Rodrigo B Abreu; Giuseppe A Sautto; Greg A Kirchenbaum; Elliott Drabek; Kevin S Williamson; Dongkyoon Kim; Daniel E Emerling; Ted M Ross
Journal:  PLoS One       Date:  2021-02-22       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.